News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
722,031 Results
Type
Article (40930)
Company Profile (267)
Press Release (680824)
Multimedia
Podcasts (81)
Webinars (17)
Section
Business (204677)
Career Advice (2024)
Deals (35535)
Drug Delivery (111)
Drug Development (81389)
Employer Resources (173)
FDA (16416)
Job Trends (14945)
News (346408)
Policy (32729)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2568)
Accelerated approval (34)
Adcomms (24)
Allergies (142)
Alliances (49575)
ALS (170)
Alzheimer's disease (1671)
Antibody-drug conjugate (ADC) (313)
Approvals (16688)
Artificial intelligence (515)
Autoimmune disease (159)
Automation (41)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (192)
Biotechnology (174)
Bladder cancer (158)
Brain cancer (57)
Breast cancer (640)
Cancer (4828)
Cardiovascular disease (402)
Career advice (1709)
Career pathing (36)
CAR-T (284)
CDC (45)
Celiac Disease (2)
Cell therapy (748)
Cervical cancer (36)
Clinical research (69595)
Collaboration (1710)
Company closure (4)
Compensation (1167)
Complete response letters (57)
COVID-19 (2713)
CRISPR (93)
C-suite (855)
Cystic fibrosis (143)
Data (6261)
Decentralized trials (2)
Denatured (25)
Depression (134)
Diabetes (502)
Diagnostics (6698)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (254)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (233)
Earnings (90227)
Editorial (57)
Employer branding (21)
Employer resources (152)
Events (117347)
Executive appointments (979)
FDA (19552)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1474)
Gene editing (199)
Generative AI (43)
Gene therapy (597)
GLP-1 (966)
Government (4663)
Grass and pollen (6)
Guidances (384)
Healthcare (18878)
HIV (60)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (254)
Immuno-oncology (57)
Indications (115)
Infectious disease (2987)
Inflammatory bowel disease (191)
Inflation Reduction Act (14)
Influenza (118)
Intellectual property (254)
Interviews (315)
IPO (16645)
IRA (50)
Job creations (3642)
Job search strategy (1428)
JPM (57)
Kidney cancer (16)
Labor market (86)
Layoffs (547)
Leadership (32)
Legal (7951)
Liver cancer (91)
Longevity (14)
Lung cancer (652)
Lymphoma (379)
Machine learning (42)
Management (59)
Manufacturing (803)
MASH (164)
Medical device (13775)
Medtech (13829)
Mergers & acquisitions (19966)
Metabolic disorders (1271)
Multiple sclerosis (163)
NASH (16)
Neurodegenerative disease (319)
Neuropsychiatric disorders (88)
Neuroscience (2909)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4515)
Now hiring (67)
Obesity (597)
Opinion (261)
Ovarian cancer (166)
Pain (198)
Pancreatic cancer (228)
Parkinson's disease (281)
Partnered (33)
Patents (505)
Patient recruitment (494)
Peanut (56)
People (58894)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21695)
Phase 2 (30628)
Phase 3 (22819)
Pipeline (5383)
Policy (284)
Postmarket research (2564)
Preclinical (9201)
Press Release (64)
Prostate cancer (238)
Psychedelics (48)
Radiopharmaceuticals (282)
Rare diseases (841)
Real estate (5954)
Recruiting (70)
Regulatory (24526)
Reports (53)
Research institute (2389)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (79)
Schizophrenia (148)
Series A (240)
Series B (190)
Service/supplier (11)
Sickle cell disease (97)
Special edition (22)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3615)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (84)
The Weekly (54)
Vaccines (1012)
Venture capital (89)
Weight loss (381)
Women's health (92)
Worklife (18)
Date
Today (160)
Last 7 days (583)
Last 30 days (2250)
Last 365 days (29932)
2026 (3748)
2025 (30172)
2024 (35216)
2023 (40078)
2022 (51175)
2021 (55711)
2020 (54083)
2019 (46539)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37553)
2014 (31318)
2013 (26345)
2012 (28571)
2011 (29263)
2010 (27329)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (309)
Arkansas (13)
Asia (39232)
Australia (6413)
California (11348)
Canada (3302)
China (1102)
Colorado (479)
Connecticut (480)
Delaware (339)
Europe (84572)
Florida (1704)
Georgia (358)
Hawaii (3)
Idaho (61)
Illinois (865)
India (67)
Indiana (524)
Iowa (22)
Japan (433)
Kansas (127)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1387)
Massachusetts (8117)
Michigan (326)
Minnesota (630)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (3014)
New Mexico (28)
New York (2990)
North Carolina (1461)
North Dakota (8)
Northern California (5548)
Ohio (334)
Oklahoma (21)
Oregon (41)
Pennsylvania (2290)
Puerto Rico (24)
Rhode Island (48)
South America (1108)
South Carolina (66)
South Dakota (1)
Southern California (4421)
Tennessee (176)
Texas (1750)
United States (40213)
Utah (337)
Vermont (1)
Virginia (264)
Washington D.C. (81)
Washington State (923)
West Virginia (4)
Wisconsin (110)
Wyoming (2)
722,031 Results for "lyell immunopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lyell Immunopharma Announces Initiation of Patient Dosing in First-of-Its-Kind Phase 3 Head-To-Head CAR T-Cell Clinical Trial in Aggressive Large B-Cell Lymphoma
February 12, 2026
·
8 min read
Press Releases
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2025
November 13, 2025
·
22 min read
Press Releases
Lyell Immunopharma Announces Participation in September 2025 Investor Conferences
September 3, 2025
·
3 min read
Press Releases
Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer
November 10, 2025
·
10 min read
Press Releases
Lyell Immunopharma Announces up to $100 Million Equity Private Placement
July 28, 2025
·
6 min read
Press Releases
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025
August 13, 2025
·
19 min read
Press Releases
Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition
December 8, 2025
·
13 min read
Press Releases
Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series
June 24, 2025
·
3 min read
Press Releases
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
June 5, 2025
·
1 min read
Press Releases
Lyell Immunopharma Strengthens Clinical and Commercial Capabilities with Key Board and Executive Appointments
June 10, 2025
·
8 min read
1 of 72,204
Next
